1. Fundacio Privada Institut D'investigacio Oncologica De Vall Hebron (2 from 7 patents)

2. Fundacio Privada Institut D'investigacio Oncologica Vall D'hebron (vhio) (2 from 2 patents)

3. Fundacio Privada Institutcio Catalana De Recerca I Estudis Avancats (icrea) (2 from 2 patents)

4. Medimmune Limited (1 from 541 patents)

5. Fundacio Privada Institucio Catalana De Recerca I Estudis Avancats (1 from 2 patents)

6. Fundacio Privada Institut D'investigacio Oncologic (1 from 1 patent)

7. Fundacio Privada Institut De Recerca Hospital Universitari Vall Hebron (ir-huvh) (1 from 1 patent)

8. Fundació Privada Institut D'investigatió Oncológica De Vall Hebron (Vhio) (1 from 1 patent)

9. Fundacio Privada Institut D'investigatio Oncologica Vall De'hebron (vhio) (1 from 1 patent)

10. Fundacio Privada Institucio Catalana De Recerca I Estudis Avancats (icrea) (1 from 1 patent)

11. Fundacio Privada Institut De Recerca Hospital Universitatri Vall Hebron (ir-huvh) (1 from 1 patent)

12. Fundació Privada Institució Catalana De Recerca | Estudis Avançats (1 from 1 patent)

13. Mosaic Biomedicals, S.l. (1 from 1 patent)

14. Mosaic Biomedicals Slu (1 from 1 patent)

15. Fundacio Privada Institut D'investigacio Oncologica De Vall D'hebron (2 patents)

1. 11999782 - Therapeutic agents for the treatment of diseases associated with undesired cell proliferation

2. 11390670 - Antibodies against LIF and uses thereof

3. 10968273 - Antibody recognizing human leukemia inhibitory factor (LIF) and use of anti-LIF antibodies in the treatment of diseases associated with unwanted cell proliferation

4. 10583191 - Antibodies against LIF and uses thereof

5. 10206999 - Antibodies against LIF and uses thereof

6. 10100112 - Therapeutic agents for the treatment of diseases associated with undesired cell proliferation

7. 8926956 - Antibody recognizing human leukemia inhibitory factor (LIF)